Gestational Diabetes Sreening in Wangsapung Hospital
Keywords:
Screening GDM, IADPSG, Carpenter and Coustan, Wangsapung HospitalAbstract
Introduction: Gestational diabetes mellitus (GDM) screening is useful in caring mother and baby. Carpenter&Coustancriteria is useful in predicting type 2 Diabetes mellitus of the mother (2 step screening), but International association of diabetes and pregnancy study groups (IADPSG) criteria attempt to redefine GDM in terms of adverse pregnancy outcomes (macrosomia, LGA infant, shoulder dystocia) by universal screening 75 g OGTT that can detect GDM in 3 times higher than Carpenter and Coustan criteria.
Method: Wangsapung Hospital screened GDM along American Diabetes Association 2010 criteria (2 step screening, take a 50 g glucose challenge test (GCT) in moderate risk group (cut-off point is >130 mg/dl), take 75 g OGTT in high risk group and positive glucose challenge test group). Risk factor was modified to fit in condition in 2010 (cut-off BMI value in obesity for Asian is 27). Data was recorded in HosXp& Microsoft Access Program in antenatal care clinic 2011-2017 that include 6622 pregnancies, then observe the incidence of GDM, rate of the risk factor, and estimated the cost.
Result: This study include 6,622 pregnancies. The mean age of population was 28.5 year (SD 5.94). The everage of initial gastational age was 23.18 weeks (SD 6.8). The pregnancy were tested GCT or OGTT 53.49% (3542/6622). The Average GDM incidence was 10.72% (712/6622; 6.62%-16.90%).
Conclusion: The use ADA 2010 recommendation for screening GDM is easy in application to reduce waiting time for the patients (100 g OGTT: 3 hrvs 75 g OGTT: 2 hr), to reduce the expense of the hospital (46.51% reduction compare to IADPSG that test 75 g OGTT in all pregnancy.
References
2. สุชยา ลือวรรณ .โรคเบาหวานในสตรีตั้งครรภ์. OB GYN CMU [Internet]. 2015 [cited 2015 Feb 23]. Available from http://www.med.cmu.ac.th/dept/obgyn/2011/index.php?option=com_content&view=article&id=1094:2015-02-23-01-52-19&catid=38&Itemid=480.
3. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001. Gestational diabetes. ObstetGynecol2001 Sep; 98(3): 525-38.
4. Donal R. Coustan. Gestational Diabetes. In Maureen IH, Catherine CC, Michael PS, Edward JB, editors. Diabetes of America. 2nd ed. MSC 6600: Bethesda MD; 1995. p. 703-718.
5. Committee opinion no. 504: screening and diagnosis of gestational diabetes mellitus. ObstetGynecol 2011 Sep; 118(3): 751-3
6. Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010 Mar; 33(3): 676-82.
7. Houshmand A, Jensen DM, Mathiesen ER, Damm P. Evolution of diagnostic criteria for gestational diabetes mellitus.Acta ObstetGynecolScnd. 2013; 92(7): 739-745.
8. Horvath k, Koch K, Jeitler K, et al Effects of treatment in woman with gestational diabetes mellitus: systemic review and metaanalysis. BMJ. 2010; 340: c1395.
9. Long H, Cundy T. Establishing consensus in the diagnosis of gestational diabetes following HAPO: where do we stand? CurrDiab Rep. 2013; 13(1): 43-50.
10. Yashdeep Gupta, BhartiKalra, Manash P Baruah. Updated guidelines on screening for gestational diabetes. International Journal of Women’s Health 2015; 7: 539–550.
11. Moses RG, Cheung NW. Point: universal screening for gestational diabetes mellitus. Diabetes Care. 2009; 32(7): 1349-1351.
12. American Diabetic Association. Diagnosis and Classification of Diabetes Mellitus.Diabetes Care. 2010; 33: S62-69.
Downloads
Published
How to Cite
Issue
Section
License
การละเมิดลิขสิทธิ์ถือเป็นความรับผิดชอบของผู้ส่งบทความโดยตรง
ผลงานที่ได้รับการตีพิมพ์ถือเป็นลิขสิทธิ์ของผู้นิพนธ์ ขอสงวนสิทธิ์มิให้นำเนื้อหา ทัศนะ หรือข้อคิดเห็นใด ๆ ของบทความในวารสารไปเผยแพร่ทางการค้าก่อนได้รับอนุญาตจากกองบรรณาธิการ อย่างเป็นลายลักษณ์อักษร